CY1324A - Antibacterial compositions containing chlorhexidine - Google Patents
Antibacterial compositions containing chlorhexidine Download PDFInfo
- Publication number
- CY1324A CY1324A CY1324A CY132480A CY1324A CY 1324 A CY1324 A CY 1324A CY 1324 A CY1324 A CY 1324A CY 132480 A CY132480 A CY 132480A CY 1324 A CY1324 A CY 1324A
- Authority
- CY
- Cyprus
- Prior art keywords
- chlorhexidine
- pharmaceutically acceptable
- salt
- acid
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
- C07C279/265—X and Y being nitrogen atoms, i.e. biguanides containing two or more biguanide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
- C07C57/10—Sorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3834—Aromatic acids (P-C aromatic linkage)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3359379A | 1979-04-26 | 1979-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1324A true CY1324A (en) | 1986-06-27 |
Family
ID=21871298
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1324A CY1324A (en) | 1979-04-26 | 1980-04-25 | Antibacterial compositions containing chlorhexidine |
CY1316A CY1316A (en) | 1979-04-26 | 1980-04-25 | Chlorhexidine salts and compositions of same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1316A CY1316A (en) | 1979-04-26 | 1980-04-25 | Chlorhexidine salts and compositions of same |
Country Status (13)
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
WO2006099358A2 (en) | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
JP2008533048A (ja) | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 耳の感染症の治療方法 |
EP2497459B1 (en) | 2005-03-10 | 2019-04-24 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
WO2011061272A2 (en) * | 2009-11-18 | 2011-05-26 | Medichem S.A. | A di(4-chloro-phenyldiguanido) derivative which is free of potential genotoxicity and a process for reducing the residual amount of p-chloroaniline in said di(4-chloro-phenyldiguanido) derivative |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB815800A (en) * | 1956-06-06 | 1959-07-01 | Ici Ltd | New biguanide salts |
US2684924A (en) * | 1951-02-05 | 1954-07-27 | Ici Ltd | Nu-chlorophenyldiguanidino compounds |
US2990425A (en) * | 1956-06-06 | 1961-06-27 | Ici Ltd | New biguanide salts |
US3159537A (en) * | 1960-12-20 | 1964-12-01 | American Cyanamid Co | Potentiation of tetracycline by phosphinic acid |
BE612641A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1961-01-18 | |||
US3794723A (en) * | 1970-03-10 | 1974-02-26 | Smithkline Corp | Complexes of phosphanilic acid and 9-amino-3-nitroacridine useful as antifungal or antibacterial agents |
US3694447A (en) * | 1970-03-10 | 1972-09-26 | Smith Kline French Lab | Complexes of phosphanilic acid and 9-amino-3-nitroacridine |
SE370003B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1971-05-18 | 1974-09-30 | Kema Nord Ab | |
GB1338003A (en) * | 1971-06-18 | 1973-11-21 | Ici Ltd | Cleaning compositions |
SE374658B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1972-07-31 | 1975-03-17 | Hesselgren S G | |
US3976765A (en) * | 1973-11-01 | 1976-08-24 | Colgate-Palmolive Company | Antibacterial oral preparations |
US4125610A (en) * | 1977-07-27 | 1978-11-14 | Bristol-Myers Company | Antibacterial compositions |
-
1980
- 1980-04-23 CA CA000350482A patent/CA1159834A/en not_active Expired
- 1980-04-24 IT IT48512/80A patent/IT1188929B/it active
- 1980-04-25 ES ES490947A patent/ES8105259A1/es not_active Expired
- 1980-04-25 DE DE19803016110 patent/DE3016110A1/de active Granted
- 1980-04-25 CH CH322480A patent/CH646948A5/de not_active IP Right Cessation
- 1980-04-25 JP JP5439280A patent/JPS55149242A/ja active Pending
- 1980-04-25 GB GB8013786A patent/GB2053195B/en not_active Expired
- 1980-04-25 CY CY1324A patent/CY1324A/en unknown
- 1980-04-25 FR FR8009398A patent/FR2455034A1/fr active Granted
- 1980-04-25 CH CH3086/84A patent/CH648755A5/de not_active IP Right Cessation
- 1980-04-25 CY CY1316A patent/CY1316A/en unknown
- 1980-04-28 AT AT0227880A patent/AT373235B/de not_active IP Right Cessation
- 1980-04-28 NL NL8002483A patent/NL8002483A/nl not_active Application Discontinuation
-
1982
- 1982-10-13 GB GB08229195A patent/GB2118041B/en not_active Expired
-
1986
- 1986-01-09 HK HK14/86A patent/HK1486A/xx unknown
- 1986-03-27 HK HK212/86A patent/HK21286A/xx unknown
- 1986-12-30 MY MY498/86A patent/MY8600498A/xx unknown
- 1986-12-30 MY MY495/86A patent/MY8600495A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CH648755A5 (de) | 1985-04-15 |
MY8600498A (en) | 1986-12-31 |
FR2455034B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-08-10 |
HK21286A (en) | 1986-04-04 |
GB2118041A (en) | 1983-10-26 |
CA1159834A (en) | 1984-01-03 |
CY1316A (en) | 1986-03-28 |
MY8600495A (en) | 1986-12-31 |
IT1188929B (it) | 1988-01-28 |
GB2053195A (en) | 1981-02-04 |
ATA227880A (de) | 1983-05-15 |
NL8002483A (nl) | 1980-10-28 |
IT8048512A1 (it) | 1981-10-24 |
DE3016110C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-12-13 |
DE3016110A1 (de) | 1980-11-06 |
CH646948A5 (de) | 1984-12-28 |
ES490947A0 (es) | 1981-05-16 |
IT8048512A0 (it) | 1980-04-24 |
GB2118041B (en) | 1984-03-21 |
AT373235B (de) | 1983-12-27 |
HK1486A (en) | 1986-01-17 |
ES8105259A1 (es) | 1981-05-16 |
FR2455034A1 (fr) | 1980-11-21 |
GB2053195B (en) | 1983-04-07 |
JPS55149242A (en) | 1980-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4666896A (en) | Chlorhexidine salts and compositions of same | |
DE69113604T2 (de) | Quinoloncarbonsäurederivat. | |
GB2079270A (en) | Imidazo-rifamycin derivatives | |
EP0049593B1 (en) | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid and metal salts thereof useful in burn therapy | |
US5747484A (en) | Crystalline cepham acid addition salts and processes for their preparation | |
GB2064513A (en) | Cephalosporin antibiotic | |
CY1324A (en) | Antibacterial compositions containing chlorhexidine | |
EP0237495B1 (en) | Halogenides of the ester of 2,n,n,n-dimethyl-alkyl-amino-ethanol with substituted acetic acid and pharmaceutical compositions having antiinflammatory and antiseptic activities containing same | |
US3707482A (en) | Carbamate derivatives of 2h-pyran-3(6h)-one | |
CA1166155A (en) | Method for inhibiting the growth of a microorganism on an inanimate substrate | |
CA1148863A (en) | Chlorhexidine salts and compositions of same | |
US4141968A (en) | Novel salts of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine in compositions having bacteriostatic activity | |
DE2629926A1 (de) | Clavulansaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
JPS63165381A (ja) | [3s(z)]−2−[[[1−(2−アミノ−4−チアゾリル)−2−[[2,2−ジメチル−4−オキソ−1−(スルホオキシ)−3−アゼチジニル]アミノ]−2−オキソエチリデン]アミノ]オキシ]酢酸の結晶塩 | |
US5142076A (en) | Metallo-organic salt compounds and pharmaceutical uses thereof | |
US4226808A (en) | 1-Aryl-2-dihalogenodeuterioalkanoylamido-1,3-propanediol antibacterial agents | |
US5556879A (en) | Aqueous spectinomycin borate solutions | |
US3324003A (en) | Method of controlling growth of bacteria using 4-methyl-1-benzo[f]quinolone-2-carboxylic acid | |
US4142050A (en) | Salts of 1,3-bis(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine | |
US3574209A (en) | Quaternary ammonium salts of methenamine | |
IE49930B1 (en) | Water-soluble hydrazones of 3-formylrifamycin sv | |
AT405180B (de) | Neue derivate von substituierten 3-cephem-4-carbonsäurederivaten und verfahren zu deren herstellung | |
CA1175356A (en) | Chlorhexidine salts and compositions of same | |
CA2214327C (en) | Aqueous spectinomycin borate solutions | |
US7001886B2 (en) | Hot melt method for preparing diphenhydramine tannate |